Abstract:The pro-inflammatory, innate-immune system ribonucleic acid mediator microRNA-146a, constitutively expressed in the brain and central nervous system (CNS) of both the mouse and the human, is pathologically up-regulated in multiple transmissible spongiform encephalopathies (TSEs) to several times its basal level. miRNA-146a: (i) exists as a ~22-ribonucleotide (nt) single-stranded non-coding RNA (sncRNA) whose sequence is unique and highly selected over evolution; (ii) is brain-, CNS- and lymphoid-tissue enriched and exhibits a 100% RNA sequence homology between the mouse and the human; (iii) has been repeatedly shown to play critical immunological and pro-inflammatory roles in the onset and propagation of several human CNS disorders including progressive, incapacitating, and lethal neurological syndromes that include prion disease (PrD) and Alzheimer's disease (AD); (iv) is a fascinating molecular entity because it is representative of the smallest class of soluble, information-carrying, amphipathic sncRNA yet described; (v) has capability to be induced by cellular stressors and the pro-inflammatory transcription factor NF-kB (p50/p65); (vi) has capability to post-transcriptionally regulate multiple mRNAs and cellular processes in neurological health and disease; (vii) is upregulated in human host cells after viral invasion by single-stranded RNA (ssRNA) or double-stranded DNA (dsDNA) neurotropic viruses; and (viii) has an immense potential in neuro-degenerative disease therapeutics via anti-NF-kB and/or anti-miRNA-146a treatment strategies. In this short communication we provide for the first time evidence that miRNA-146a is a prominent sncRNA species in experimental murine prion disease, progressively increasing in the pre-symptomatic stages in C57BL/6J, SJL/J or Swiss Albino murine scrapie prion models. The highest miRNA-146a levels were quantified in these three different murine scrapie models exhibiting full symptomology of prion infection. The results suggest that miRNA-146a levels in the brain may be useful as an accessory diagnostic, prognostic or response-to-treatment biomarker to monitor the onset and development of PrD in experimental murine models that may also be extrapolated to be a relevant adjunct biomarker in human TSEs.

Analysis of miRNA expression profiles in exosomes of SMB-S15 cells treated with resveratrol

Infection of Prions and Treatment of PrP106–126 Alter the Endogenous Status of Protein 14-3-3 and Trigger the Mitochondrial Apoptosis Possibly via Activating Bax Pathway

Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.

Treatment of SMB-S15 Cells with Resveratrol Efficiently Removes the PrPSc Accumulation in Vitro and Prion Infectivity in Vivo

Expressions of prion disease-related miRNA in various pathogenic organs and cells

Mirna Expression Profiles in the Brains of Mice Infected with Scrapie Agents 139a, Me7 and S15

Extensive Disturbances of Intracellular Components and Dysfunctions of Biological Pathways in the Brain Tissues During Prion Infection — China’s Studies

Systematic Identification and Comparison of the Expressed Profiles of Exosomal MiRNAs in Pigs Infected with NADC30-like PRRSV Strain

MicroRNA in the Exosomes Mediated by Resveratrol to Activate Neuronal Cells

Exosomal Mirnas in Central Nervous System Diseases: Biomarkers, Pathological Mediators, Protective Factors and Therapeutic Agents.

RNA-sequencing transcriptomic analysis of scrapie-exposed ovine mesenchymal stem cells

Exosomal Microrna Profiles from Serum and Cerebrospinal Fluid in Neurosyphilis.

Microrna-146A As a Biomarker for Transmissible Spongiform Encephalopathy.

MicroRNA and prion disease

Brain-Derived Exosomal Mirna Profiles Upon Experimental SAE Rats and Their Comparison with Peripheral Exosomes.

PrPSc Inhibition and Cellular Protection of DBL on a Prion-Infected Cultured Cell via Multiple Pathways

Identification of microRNAs implicated in modulating resveratrol-induced apoptosis in porcine granulosa cells

Circulating Small Extracellular Vesicle-Derived Mir-342-5p Ameliorates Beta-Amyloid Formation Via Targeting Beta-site APP Cleaving Enzyme 1 in Alzheimer’s Disease

Integrated Mirna and Mrna Transcriptomes of Porcine Alveolar Macrophages (PAM Cells) Identifies Strain-Specific Mirna Molecular Signatures Associated with H-PRRSV and N-PRRSV Infection

MicroRNA transcriptome analysis of poly I:C-stimulated and PRRSV-infected porcine alveolar macrophages

Exploring the tissue tropism of pseudorabies virus based on miRNA level analysis